Blood-based monitoring identifies acquired and targetable driver HER2 mutations in endocrine-resistant metastatic breast cancer
通过血液监测可识别内分泌耐药转移性乳腺癌中的获得性和可靶向 HER2 驱动突变
期刊:npj Precision Oncology
影响因子:6.8
doi:10.1038/s41698-019-0090-5
Arielle J Medford #, Taronish D Dubash #, Dejan Juric, Laura Spring, Andrzej Niemierko, Neelima Vidula, Jeffrey Peppercorn, Steven Isakoff, Brittany A Reeves, Joseph A LiCausi, Benjamin Wesley, Giuliana Malvarosa, Megan Yuen, Ben S Wittner, Michael S Lawrence, A John Iafrate, Leif Ellisen, Beverly M